“Healthcare’s administrative burden did not arrive fully formed, roaring across the landscape.
It accumulated quietly—policy by policy, form by form, requirement by requirement—until the atmosphere was primed for a fire.
And once lit, it spread faster than anyone was willing, or able, to contain it.”
Find the rest on substack (link below) 👇 👇👇👇👇👇
@pgipe@txsportsdoc I am surprised that the docs agreed to that. Every handoff is another hole in the cheese.
I like seeing my own hospital patients, But I realize that isn’t practical these days in large systems.
Insurance claims denial letters are starting to sound like break-up texts:
It's not you, it's us. We just don't find this treatment medically necessary right now.
(TBH it's usually more like... It's not you and it's not us... It's your doctor. It's all her fault.)
Ai-Generated content is really annoying.
2 and 3 word sentences
quietly
Not ___, but ____
Vibes
overuse of adjectives and adverbs
It's really easy to spot, and it's not good writing.
The irony is that some champion AI as "efficient prose."
If so, I don't like efficient prose. I like Welty and even Grisham.... but don't give me AI to read seriously.
@WSJopinion I skimmed the report when it came out a few weeks ago... and wasn't shocked.
But I'm also not privy to the power-play in Washington either between these groups.
Breaking: Showdown of the Century: Bobby Tyson vs. Doctor Oz
LAS VEGAS, NV – The showdown of the century is scheduled for this Friday night...Full Story 👇👇👇
@CoveragePending for the latest news you can use
Want to know why https://t.co/39PNLwYH8U doesn't have more brands?
With a few exceptions (already has a generic, not on formularies, soon to have a generic), CPD , and every pass through smaller PBM , can't buy branded meds that have a rebate, at a competitive price.
No one is asking for rebates equal to the big 3 PBMs.
We can't even get a " walk in off the street price." We actually had one brand say in a meeting they would give us a "walk in off the street price", then all the sudden they couldn't
I asked the CEO of a best selling branded med how many lives we would need to have covered before they would sell to the GPO we created, or to us in any manner, he said "half".
They couldn't sell to us until we covered half the lives the big 3 cover. He would lose placement on formulary tiers merely for offering us rebates. He couldn't afford to do business with us
This is not an efficient market. The big PBMs have threatened brands with loss of formulary positioning for their entire portfolios
This is why brand pricing continues to be high for employers
@PamBondi@AFergusonFTC